RELATING TO PRESCRIPTION DRUGS.
Summary
Requires the Department of Health to compile, analyze, and report certain information on essential prescription drugs marketed in the State for the treatment of diabetes. Requires certain entities to provide information that justifies cost increases in drug products.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2018
Committee Review
Floor Vote
Governor
Introduced Jan 24, 2018
Last action Jan 29, 2018
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jan 29, 2018
House · Referred to committee
Referred to HHS, CPC, FIN, referral sheet 9
Jan 24, 2018
House · Introduced
Introduced and Pass First Reading.
13 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Angus McKelvey
DDemocratic
P
CK
Calvin K.Y. Say
DDemocratic
P
CT
Cynthia Thielen
RRepublican
P
Dee Morikawa
DDemocratic
P
Gene Ward
RRepublican
P
KI
Ken Ito
DDemocratic
P
LR
Lei R. Learmont
DDemocratic
P
MS
Matthew S. LoPresti
DDemocratic
P
Richard Onishi
DDemocratic
P
RM
Romy M. Cachola
DDemocratic
P
SE
Sharon E. Har
DDemocratic
P
TO
Takashi Ohno
DDemocratic
P
TB
Tom Brower
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2668
Scope: HI
Hi! I can help you understand HB 2668. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline